Incidence of type 2 diabetes in Aboriginal Australians: an 11-year prospective cohort study.

Centre for Chronic Disease, School of Medicine, University of Queensland, Herston, 4029 QLD, Australia.
BMC Public Health (Impact Factor: 2.08). 01/2010; 10:487. DOI: 10.1186/1471-2458-10-487
Source: PubMed

ABSTRACT Diabetes is an important contributor to the health inequity between Aboriginal and non-Aboriginal Australians. This study aims to estimate incidence rates of diabetes and to assess its associations with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) among Aboriginal participants in a remote community.
Six hundred and eighty six (686) Aboriginal Australians aged 20 to 74 years free from diabetes at baseline were followed for a median of 11 years. During the follow-up period, new diabetes cases were identified through hospital records. Cox proportional hazards models were used to assess relationships of the incidence rates of diabetes with IFG, IGT and body mass index (BMI).
One hundred and twenty four (124) new diabetes cases were diagnosed during the follow up period. Incidence rates increased with increasing age, from 2.2 per 1000 person-years for those younger than 25 years to 39.9 per 1000 person-years for those 45-54 years. By age of 60 years, cumulative incidence rates were 49% for Aboriginal men and 70% for Aboriginal women. The rate ratio for developing diabetes in the presence of either IFG or IGT at baseline was 2.2 (95% CI: 1.5, 3.3), adjusting for age, sex and BMI. Rate ratios for developing diabetes were 2.2 (95% CI: 1.4, 3.5) for people who were overweight and 4.7 (95% CI: 3.0, 7.4) for people who were obese at baseline, with adjustment of age, sex and the presence of IFG/IGT.
Diabetes incidence rates are high in Aboriginal people. The lifetime risk of developing diabetes among Aboriginal men is one in two, and among Aboriginal women is two in three. Baseline IFG, IGT and obesity are important predictors of diabetes.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Australian Aboriginal women have a high prevalence of type 2 diabetes (T2DM) in pregnancy and gestational diabetes (GDM). AIMS: To review how screening practice affects the pregnancy data of all Indigenous women and their newborns living in Cape York, Queensland. METHODS: All medical charts of mothers and their neonates delivered in the regional hospital over two-one-year periods (2006 and 2008) were reviewed. Universal testing with an oral glucose tolerance test (OGTT) was introduced in 2007. RESULTS: Gestational diabetes (GDM) increased from 4.7 to 14.2%, and T2DM was similar (2.4 and 2.3%). There were 127 deliveries in 2006 and 134 in 2008. Testing rates with OGTT improved from 31.4% in 2006 to 65.6% in 2008. Mothers with diabetes in pregnancy (DIP) were older and heavier than non-DIP mothers. Caesarean section rates were significantly higher in the DIP group compared with the non-DIP group (66 vs 25%) in both time periods. The booking weight of DIP mothers decreased 16 kg, their babies normalised their weight, length and head circumference; respiratory distress and Apgar scores improved comparing the two periods. In DIP, infants >40% had hypoglycaemia; however, rates of serious complications were low. Rates of breastfeeding were similar between groups. Follow-up rates for GDM improved from 16.6% in 2006 to 31.6% in 2008. Of those tested one-third were diagnosed with T2DM. CONCLUSION: The rate of GDM tripled after implementation of universal testing. Outcomes improved. There is still need for improvement in testing and follow-up practices in relation to DIP.
    Australian and New Zealand Journal of Obstetrics and Gynaecology 03/2013; · 1.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Significant advances in tobacco cessation and prevention initiatives have occurred over recent years, yet smoking amongst Indigenous populations remain double that of the relevant non-Indigenous population. As such tobacco use is considered a significant risk factor contributing to health disparities among these populations. Two Cochrane systematic reviews, one evaluating tobacco cessation and the other tobacco prevention initiatives for Indigenous populations summarise the available evidence for use by policy makers, researchers and consumers alike. Culturally tailored tobacco cessation initiatives show evidence of long-term abstinence, however, both cessation and prevention initiatives specifically designed in collaboration with Indigenous cohorts are lacking. Despite the significant health burden attributed to tobacco use including the development of tobacco related illnesses and associated economic expenditures, there remains a paucity of data in this field. Methodologically rigorous collaborative research is needed to highlight the barriers and facilitators for tobacco cessation and prevention programs in order to effectively reduce the prevalence of tobacco use and subsequent co-morbidities. NOTE: This chapter (text, tables and figures) contain excerpts from articles published previously. Please refer to Carson and colleagues (2012a, 2012b and 2012c) in the reference list at the end of this chapter.
    06/2013: pages 1-38; , ISBN: 978-1-62618-570-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: The remaining lifetime risks for end stage renal disease among Aboriginal people with and without diabetes were estimated. The value for young adults with diabetes was high, about 1 in 2 at the age of 30 years, while it decreased with age to 1 in 7 at 60 years.
    Diabetes research and clinical practice 01/2014; · 2.74 Impact Factor

Full-text (3 Sources)

Available from
May 21, 2014